Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic to Present at Jefferies 2017 Global Healthcare Conference Read more about Synlogic to Present at Jefferies 2017 Global Healthcare Conference Synlogic Meets First Discovery Milestone in Partnership with AbbVie Read more about Synlogic Meets First Discovery Milestone in Partnership with AbbVie Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines Read more about Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020 Read more about Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020 Peter Barrett Member of the Audit Committee Member of the Science & Technology Committee Peter Barrett, Ph.D. Chairman of the Board Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Current page 24 Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic to Present at Jefferies 2017 Global Healthcare Conference Read more about Synlogic to Present at Jefferies 2017 Global Healthcare Conference
Synlogic Meets First Discovery Milestone in Partnership with AbbVie Read more about Synlogic Meets First Discovery Milestone in Partnership with AbbVie
Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines Read more about Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines
Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020 Read more about Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020
Peter Barrett Member of the Audit Committee Member of the Science & Technology Committee Peter Barrett, Ph.D. Chairman of the Board